Blog
Wall Street Analysts Believe Syndax (SNDX) Could Rally 112.8%: Here's is How to Trade
Syndax Pharmaceuticals (SNDX) closed the last trading session at $16.33, gaining 63.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
Wall Street Analysts Think Deluxe (DLX) Could Surge 36.06%: Read This Before Placing a Bet
Deluxe (DLX) closed the last trading session at $19.66, gaining 26.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Predict a 35.8% Upside in Ranpak Holdings (PACK): Here's What You Should Know
Ranpak Holdings Corp (PACK) closed the last trading session at $5.28, gaining 52.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Guardian Pharmacy Services (GRDN)'s Technical Outlook is Bright After Key Golden Cross
Guardian Pharmacy Services, Inc. (GRDN) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, GRDN's 50-day simple moving average broke
Does Arcutis Biotherapeutics (ARQT) Have the Potential to Rally 45.81% as Wall Street Analysts Expect?
Arcutis Biotherapeutics, Inc. (ARQT) closed the last trading session at $15.52, gaining 8.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Wall Street Analysts Believe DoubleDown Interactive (DDI) Could Rally 99.48%: Here's is How to Trade
Shares of DoubleDown Interactive Co., Ltd. Sponsored ADR (DDI) have gained 4.8% over the past four weeks to close the last trading session at $9.65, but there could still be a solid upside left in
Y-mAbs Therapeutics, Inc. (YMAB) Now Trades Above Golden Cross: Time to Buy?
After reaching an important support level, Y-mAbs Therapeutics, Inc. (YMAB) could be a good stock pick from a technical perspective. YMAB recently experienced a "golden cross" event, which saw its
Wall Street Analysts Believe ARKO (ARKO) Could Rally 32.6%: Here's is How to Trade
Shares of ARKO Corp. (ARKO) have gained 25.3% over the past four weeks to close the last trading session at $5, but there could still be a solid upside left in the stock if short-term price targets
Should You Buy Arcturus Therapeutics (ARCT) After Golden Cross?
Arcturus Therapeutics Holdings Inc. (ARCT) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, ARCT's 50-day simple moving
Wall Street Analysts Predict a 130.63% Upside in Foghorn Therapeutics (FHTX): Here's What You Should Know
Foghorn Therapeutics Inc. (FHTX) closed the last trading session at $5.06, gaining 1.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Wall Street Analysts Predict a 41.36% Upside in CI&T (CINT): Here's What You Should Know
Shares of CI&T Inc. (CINT) have gained 2.3% over the past four weeks to close the last trading session at $5.44, but there could still be a solid upside left in the stock if short-term price targets
Puma Biotech (PBYI) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
The price trend for Puma Biotech (PBYI) has been bearish lately and the stock has lost 12% over the past two weeks. However, the formation of a hammer chart pattern in its last trading session
Here's Why Ascentage Pharma Group International - Unsponsored ADR (AAPG) Is a Great 'Buy the Bottom' Stock Now
Shares of Ascentage Pharma Group International - Unsponsored ADR (AAPG) have been struggling lately and have lost 11.3% over the past week. However, a hammer chart pattern was formed in its last
Here's Why XOMA Royalty (XOMA) Is a Great 'Buy the Bottom' Stock Now
Shares of XOMA Royalty (XOMA) have been struggling lately and have lost 5.1% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the
Wall Street Analysts Think Amneal (AMRX) Could Surge 25.52%: Read This Before Placing a Bet
Shares of Amneal Pharmaceuticals (AMRX) have gained 22.1% over the past four weeks to close the last trading session at $9.56, but there could still be a solid upside left in the stock if short-term
S&T Bancorp (STBA)'s Technical Outlook is Bright After Key Golden Cross
After reaching an important support level, S&T Bancorp, Inc. (STBA) could be a good stock pick from a technical perspective. STBA recently experienced a "golden cross" event, which saw its 50-day
Boeing's Defense Unit Steers to New Heights on Expanding Backlog
The Boeing Company’s (BA) defense business has been a stabilizing pillar for the aerospace giant as its commercial division, despite showing growth traits lately, continues to face supply-chain and
ABT Stock Gains From Navitor's Expanded Indication Approval in Europe
Abbott Laboratories ABT recently received CE Mark in Europe for an expanded indication for its Navitor transcatheter aortic valve implantation (TAVI) system to treat people with symptomatic, severe
TTE & XING Mobility to Unlock High-Growth Battery Cooling Market
TotalEnergies SE TTE announced that TotalEnergies Lubrifiants and XING Mobility have signed a Memorandum of Understanding to jointly promote cutting-edge immersion cooling battery systems. In order
ExxonMobil Flags Coal Comeback as Threat to Net-Zero Goals
Exxon Mobil Corporation XOM has issued an update on the future of global emissions, warning that the world’s net-zero targets are increasingly slipping beyond the 2050 horizon, per a Bloomberg
FDA Identifies ICU Medical's Plum Duo Recall as Serious Type
ICU Medical ICUI is currently encountering a recall notice from the FDA for its Plum Duo Infusion System. The recall is for correcting certain devices with software issues, but does not involve
Is Enbridge's Business Vulnerable to Volatility in Oil & Gas Prices?
Enbridge Inc. ENB is a leading midstream energy company transporting crude oil and natural gas. Unlike exploration and production companies and refining or downstream players, Enbridge's business
Why Sonic Automotive (SAH) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Here's Why Synchrony (SYF) is a Strong Momentum Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service


